Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 18/11/20 at 11:03am

The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created side effects that felt similar to a “severe hangover”, while it has been reported that Pfizer CEO Albert Bourla sold 62% of his stock in the company on the same day the vaccine’s clinical trial results were revealed.

1. First interim Phase 3 data shows promise for Russia's Sputnik V COVID-19 vaccine - Published on 11/11/20

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF).

2. Pfizer/BioNTech vaccine side effects feel like a “severe hangover” - Published on 12/11/20

Clinical trial participants receiving the Pfizer/BioNTech coronavirus vaccine have said it created side effects that felt similar to a “severe hangover.”

3. Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data - Published on 12/11/20

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it has been reported that Pfizer CEO Albert Bourla sold 62% of his stock in the company on the same day the results were unveiled.

4. Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says - Published on 11/11/20

Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study.

5. Pfizer launches pilot delivery programme for its coronavirus vaccine - Published on 17/11/20

Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be located in multiple sites across America; the company said it has selected New Mexico, Tennessee, Rhode Island and Texas for the programme because of their differences in size and immunisation infrastructure.

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches